The second focus on my research is the development of novel therapeutic vaccine approaches for cancer. (robarts.ca)
One new vaccine approach prompts the body to make antibodies to the more stable stem. (sciencenews.org)
They will also work with Vir Biotechnology, Inc. of San Francisco, which has licensed aspects of their CMV - based vaccine approach, to expand testing with plans to start a human clinical trial in 2020. (sciencedaily.com)